Literature DB >> 31591105

Longitudinal Pattern of First-Phase Insulin Response Is Associated With Genetic Variants Outside the Class II HLA Region in Children With Multiple Autoantibodies.

Maarit K Koskinen1,2, Mari-Liis Mikk3, Antti-Pekka Laine3, Johanna Lempainen4,3, Eliisa Löyttyniemi5, Paula Vähäsalo6, Anne Hekkala6, Taina Härkönen7,8, Minna Kiviniemi3, Olli Simell4, Mikael Knip7,8,9,10, Riitta Veijola6, Jorma Ilonen3, Jorma Toppari4,11.   

Abstract

A declining first-phase insulin response (FPIR) is associated with positivity for multiple islet autoantibodies, irrespective of class II HLA DR-DQ genotype. We examined the associations of FPIR with genetic variants outside the HLA DR-DQ region in the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study in children with and without multiple autoantibodies. Association between FPIR and class I alleles A*24 and B*39 and eight single nucleotide polymorphisms outside the HLA region were analyzed in 438 children who had one or more FPIR results available after seroconversion. Hierarchical linear mixed models were used to analyze repeated measurements of FPIR. In children with multiple autoantibodies, the change in FPIR over time was significantly different between those with various PTPN2 (rs45450798), FUT2 (rs601338), CTSH (rs3825932), and IKZF4 (rs1701704) genotypes in at least one of the models. In general, children carrying susceptibility alleles for type 1 diabetes experienced a more rapid decline in insulin secretion compared with children without susceptibility alleles. The presence of the class I HLA A*24 allele was also associated with a steeper decline of FPIR over time in children with multiple autoantibodies. Certain genetic variants outside the class II HLA region may have a significant impact on the longitudinal pattern of FPIR.
© 2019 by the American Diabetes Association.

Entities:  

Year:  2019        PMID: 31591105     DOI: 10.2337/db19-0329

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  De-coding genetic risk variants in type 1 diabetes.

Authors:  Melanie R Shapiro; Puchong Thirawatananond; Leeana Peters; Robert C Sharp; Similoluwa Ogundare; Amanda L Posgai; Daniel J Perry; Todd M Brusko
Journal:  Immunol Cell Biol       Date:  2021-02-24       Impact factor: 5.126

Review 2.  Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure.

Authors:  Décio L Eizirik; Lorenzo Pasquali; Miriam Cnop
Journal:  Nat Rev Endocrinol       Date:  2020-05-12       Impact factor: 43.330

3.  Genetic and environmental factors regulate the type 1 diabetes gene CTSH via differential DNA methylation.

Authors:  Jody Ye; Mihaela Stefan-Lifshitz; Yaron Tomer
Journal:  J Biol Chem       Date:  2021-05-14       Impact factor: 5.157

Review 4.  The role of beta-cell dysfunction in early type 1 diabetes.

Authors:  Emily K Sims; Raghavendra G Mirmira; Carmella Evans-Molina
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-08       Impact factor: 3.626

Review 5.  The β-Cell Genomic Landscape in T1D: Implications for Disease Pathogenesis.

Authors:  Mireia Ramos-Rodríguez; Beatriz Pérez-González; Lorenzo Pasquali
Journal:  Curr Diab Rep       Date:  2021-01-02       Impact factor: 4.810

6.  Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA.

Authors:  Maria Månsson Martinez; Falastin Salami; Helena Elding Larsson; Jorma Toppari; Åke Lernmark; Jukka Kero; Riitta Veijola; Jaakko J Koskenniemi; Päivi Tossavainen; Markus Lundgren; Henrik Borg; Anastasia Katsarou; Marlena Maziarz; Carina Törn
Journal:  Endocrinol Diabetes Metab       Date:  2020-11-05

7.  Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA.

Authors:  Maria Månsson Martinez; Lampros Spiliopoulos; Marlena Maziarz; Carina Törn; Falastin Salami; Daniel Agardh; Jorma Toppari; Åke Lernmark; Jukka Kero; Riitta Veijola; Päivi Tossavainen; Sauli Palmu; Markus Lundgren; Henrik Borg; Anastasia Katsarou; Helena Elding Larsson; Mikael Knip
Journal:  Clin Diabetes Endocrinol       Date:  2022-01-05

8.  Non-HLA Gene Polymorphisms in the Pathogenesis of Type 1 Diabetes: Phase and Endotype Specific Effects.

Authors:  Antti-Pekka Laine; Milla Valta; Jorma Toppari; Mikael Knip; Riitta Veijola; Jorma Ilonen; Johanna Lempainen
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

Review 9.  The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.

Authors:  Steven E Kahn; Yi-Chun Chen; Nathalie Esser; Austin J Taylor; Daniël H van Raalte; Sakeneh Zraika; C Bruce Verchere
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 25.261

10.  HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetes.

Authors:  Ziyu Jiang; Wenqian Ren; Hua Liang; Jinhua Yan; Daizhi Yang; Sihui Luo; Xueying Zheng; Guo-Wang Lin; Yingxin Xian; Wen Xu; Bin Yao; Janelle A Noble; Jin-Xin Bei; Leif Groop; Jianping Weng
Journal:  Diabetologia       Date:  2021-05-22       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.